2750119-14-1
2750119-14-1
Chemical Structure
6PPD-quinone-d5
- CAS No.: 2750119-14-1
- Formula:C18H17D5N2O2
- Molecular Weight:303.41
IUPAC Name: 2-((4-methylpentan-2-yl)amino)-5-((phenyl-d5)amino)cyclohexa-2,5-diene-1,4-dione
InChIKey: UBMGKRIXKUIXFQ-UPKDRLQUSA-N
SMILES: O=C(C=C1NC(C)CC(C)C)C(NC2=C([2H])C([2H])=C([2H])C([2H])=C2[2H])=CC1=O
Biological Activity: 6PPD-quinone-d5 is the deuterium labeled 6PPD-quinone[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
6PPD-quinone-d5 | 99.89% | 6PPD-quinone-d5 is the deuterium labeled 6PPD-quinone. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
6PPD-Q (Standard) | ≥98% | 6PPD-Q (Standard) is the analytical standard of 6PPD-Q (HY-153169). This product is intended for research and analytical applications. 6PPD-Q (6PPD-Quinone) is an environmental pollutant that can be detected in human urine and is widely present in the environment. 6PPD-Q targets and binds to CNR2, CNR1, AA2AR, LCAT, and TRPA1, with CNR2 exhibiting the highest binding affinity, potentially acting as a CNR2 receptor agonist to activate cannabinoid receptors. 6PPD-Q induces intestinal inflammation and barrier damage by disrupting mitochondrial function, reducing neuronal glycolysis metabolites and TCA cycle intermediates, and exacerbating α-synuclein (α-syn) aggregation. 6PPD-Q is applicable in research on environmental toxicology, neurodegenerative diseases, and inflammation-related disorders. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
6PPD-Q-13C6 | 98.0% | 6PPD-quinone-13C6 is the 13C labeled 6PPD-quinone. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
6PPD-Q | 99.77% | 6PPD-Q (6PPD-Quinone) is an environmental pollutant that can be detected in human urine and is widely present in the environment. 6PPD-Q targets and binds to CNR2, CNR1, AA2AR, LCAT, and TRPA1, with CNR2 exhibiting the highest binding affinity, potentially acting as a CNR2 receptor agonist to activate cannabinoid receptors. 6PPD-Q induces intestinal inflammation and barrier damage by disrupting mitochondrial function, reducing neuronal glycolysis metabolites and TCA cycle intermediates, and exacerbating α-synuclein (α-syn) aggregation. 6PPD-Q is applicable in research on environmental toxicology, neurodegenerative diseases, and inflammation-related disorders. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
